Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

The Regeneron litigation highlights that donations routed through independent entities are not immune from challenge, especially if the government believes they are effectively covering a patient’s co ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...

Donald Trump plans to impose new tariffs on pharmaceuticals and semiconductors to boost manufacturing in the US.